Jinx, a 9 month old black Labrador, has become the first patient at Peterborough's recently-opened NuVet practice to undergo pioneering 'single port' keyhole surgery for a retained testicle
The operation was performed by Marwan Tarazi, owner of the NuVet practice, using Biovision SurgAssist laproscopic equipment.
Marwan said: "When we opened the NuVet practice in May, we wanted to offer our clients the option for less invasive surgical techniques wherever possible. Jinx's condition made him a good candidate for keyhole surgery, and the 'single port' approach we use reduces the risk of post-operative infection and speeds up recovery time. His owner nursed another dog through serious complications following more traditional cryptorchid surgery twenty years ago, so she was very keen to try a less invasive approach. This time the procedure went without a hitch and Jinx was very quickly back to his old self, helped by plenty of love and attention from all our staff".
Jinx's owner is delighted with the results. She said: "I had heard that NuVet were doing procedures through keyhole surgery and so I took Jinx along to the practice in Bretton. All the staff were very welcoming and helpful, and the vet explained the procedure thoroughly beforehand, showing me both the theatre and the equipment he would use, which helped to reassure me. When I went to pick Jinx up after the surgery, he came out wagging his tail, and two days later he was back to his normal self - running around and jumping over impossibly high fences!
"20 years ago I had a German Shepherd with the same condition. Then the vet had to open him up with a large incision, and it was very stressful and uncomfortable for the dog. The recovery time for him was 10-14 days, compared to Jinx's of around 2 days. The difference was amazing."
Marwan is one of a very small number of vets in the UK to use the 'single port' technique. He has invested tens of thousands of pounds in training and equipment to allow the NuVet practice to offer this specialised service to the pets of Peterborough and beyond.
If you want to know more about this procedure and the equipment being used, click here to talk to Marwan!
See also: www.nuvet.co.uk
Two new edition's of Veterinary Focus, Royal Canin's free journal for companion animal veterinary surgeons are now available free of charge to UK vets.
Focus on Respiratory Disease includes features on brachycephalic syndrome, feline asthma, thoracic radiography of respiratory cases, canine fungal rhinitis, tracheobronchial foreign bodies in dogs and cats, emergency care of patients with acute respiratory distress, and respiratory parasitic diseases. Contributors include representatives from veterinary universities in Germany, Spain, Italy, the USA, and Argentina, and from the UK, Martin Sullivan BVMS, PhD, DVR, Dipl. ECVDI, MRCVS from Glasgow University and Mike Stafford Johnson, MVB, MRCVS, DVC Cert, SAM, MACVS from the Veterinary Cardiorespiratory Centre in Kenilworth.
Focus on Liver Disease includes features on feline inflammatory liver disease, canine portosystemic shunts, jaundice in the dog, extra-hepatic biliary system surgery, laboratory tests for liver disease, liver enzyme testing, diagnosis and treatment of liver tumours, and liver biopsy sampling. Contributors include representatives from veterinary universities in France, Spain, Italy, the USA, New Caledonia, Argentina, and Grenada, and from the Faculty of Veterinary Medicine, University of Edinburgh, Danielle Gunn-Moore, BSc. BVM&S, PhD, FHEA, MACVSc, MRCVS, Nicki Reed, BM&S, Cert VR.DSAM (Feline) Dipl. ECVIM-CA, MRCVS, and Kathryn Pratschke, MVB. MVM, Cert SAS, Dipl. ECVS, MRCVS.
Lee Danks, Royal Canin Veterinary Support manager, said: "Focus is a really interesting and informative publication, and with each issue focusing on a particular body system it offers a complete review of the latest thinking in each area. The contributors are all highly renowned in their individual fields, and being able to provide this kind of expertise to our veterinary partners is something we are really proud of."
Veterinary Focus is published in English, French, German, Chinese, Italian, Polish, Portuguese, Spanish, Japanese, Greek and Russian and reaches over 80,000 veterinary surgeons worldwide.
For a free copy of Focus, speak to your Royal Canin veterinary business manager, who will add you to the subscription list.
Following a nationwide search to find the UK’s top veterinary professionals for 2008 and judged by an independent panel of experts, Petplan has announced the final short-list for the Petplan Veterinary Awards to be presented on 3rd April in Birmingham.
Those short-listed for the four categories of the Petplan Veterinary Awards acknowledging achievement in the veterinary world include:
Vet of the Year Brian Faulkner of the Melton Veterinary Surgery, Woodbridge Linda Glenn of the Glenn Veterinary Clinic, Bangor Girish Thakral of the Blacks Veterinary Group, Dudley
Vet Nurse of the Year Louisa Baker of the Priors Leaze Veterinary Centre, Chichester Alison Devonshire of the Orwell Veterinary Group, Ipswich Mark Vince of The Animal Clinic, Catford
Vet Receptionist of the Year Margaret Coupe of the Hedge End Veterinary Health Centre, Southampton Margaret Gait of Cinque Ports Veterinary Associates, Lydd Sandie Rule of the Eastcott Veterinary Clinic, Swindon
Vet Practice of the Year Battle Flatts Veterinary Clinic, York Orwell Veterinary Group, Ipswich Woodlands Veterinary Clinic, Cheltenham
The range comprises of a detangling pre-wash, a cleansing shampoo and a fragrant conditioner, all of which are pH balanced and formulated using natural ingredients and a blend of essential oils designed to make bathtime a calmer experience.
The products all come in 300ml bottles with a list price of £6; RRP £12.
The Pet Remedy range can be ordered direct from Animalcare on 01904 487687 (orders@animalcare.co.uk) or from your veterinary wholesaler.
The journal provides free access to critical summaries of the best available evidence, called Knowledge Summaries, to help practitioners make informed evidence-based decisions in practice.
The new website has several new features, such as author and reviewer hubs, which contain information to guide contributors through the process of writing or reviewing papers for the journal.
A new ‘answer me’ button allows potential authors to pick a clinical query they are interested in answering and email it straight to the Editor, streamlining the process.
The new site also includes a new submission system, Editorial Manager, which streamlines the editorial process, communications with authors and reviewers, and the management of articles.
Kit Sturgess, Editor-in-Chief of Veterinary Evidence, says: “I am really excited by the new website; its look and functionality will significantly improve rapid access to information and further boost the engagement of the veterinary team with EBVM.
"After an impressive year for Veterinary Evidence, we have also moved to a new submission system, Editorial Manager, aimed at making the experience of submitting and reviewing papers easier and more efficient.
"Through the new website and publishing platform, the journal can get better metrics of how well we are supporting our readers, authors, and reviewers so we can use evidence to drive Quality Improvement.”
veterinaryevidence.org
The article argues that as the equine influenza (EI) vaccine supply returns to normal, there is sound scientific evidence why bi-annual vaccination schedules should be re-implemented promptly.
Whilst the scale and number of outbreaks has been relatively small since the introduction of mandatory EI vaccination by most competitive equestrian disciplines in the 1980s, disease events such as those experienced in the UK in 1989, 2003 and most recently in 2019 have demonstrated EI’s epidemic potential, even in vaccinated horse populations.
In their article 'Equine influenza bi-annual boosters: what does the evidence tell us?' Victoria Colgate and Richard Newton discuss what has been learnt from previous outbreaks and explain the evidence from mathematical models to show why bi-annual boosters are beneficial.
The authors say that epidemiological data from previous natural EI outbreaks have repeatedly demonstrated the impermanent nature of the protection provided by vaccination and observational field studies have repeatedly highlighted the potential for 12-monthly boosters to leave a vulnerable immunity gap at both the individual animal and population level.
Mathematical models of EI transmission confirm that six-monthly rather than annual EI booster vaccinations are preferable to establish and maintain effective population level immunity to EI.
Ideally vaccine strains should be updated in a timely manner to ensure inclusion of the most epidemiologically-relevant strains, however, this is a slow and expensive process for equine vaccine manufacturers.
In the absence of updated vaccine strains, bi-annual vaccination is strongly recommended to help compensate for antigenic drift between vaccine and circulating EI viral strains
Professor Celia Marr, Editor of the EVJ said: “Although the recent EI vaccine shortage has necessitated a temporary relaxation of competition vaccine schedules, we must now renew the message that six-monthly boosters are optimal and necessary.”
The Editorial can be found at https://beva.onlinelibrary.wiley.com/doi/10.1111/evj.13898 and is free to view.
Two related articles can be found here: https://beva.onlinelibrary.wiley.com/doi/10.1111/evj.13874 and here: https://beva.onlinelibrary.wiley.com/doi/10.1111/evj.13885
The requirement to treat animals entering the UK against ticks was dropped in January 2012.
Four years later, in 2016, the UK saw its first cases of Babesia canis in dogs that had not travelled abroad. MSD says it is thought the disease entered the UK carried on ticks from dogs imported from Central, Southern or Eastern Europe where the disease is rife.
Tick Awareness Month aims to highlight the need to use treatments against ticks to protect the health of pets and their owners. Vets and nurses who agree that the campaign is important are urged to write to their local parliamentary candidates explaining why introducing tick control for dogs before, during and after travel abroad is so important.
A sample letter is available on the Big Tick Project website (www.bigtickproject.co.uk).
Amanda Melvin, Marketing Manager at MSD Animal Health said: "With an election looming we want protecting UK pets and borders against non-native ticks to be on the agenda for the new Government team at DEFRA as after June 8th they start to reshape animal health policy in the UK in the build up to Brexit. If you agree that this campaign is important, during Tick Awareness Month you can get involved by writing to your local parliamentary candidates explaining why introducing tick control for dogs before, during and after travel abroad is so important."
The publicly supported Dog Control Bill moves a step closer towards changing dangerous dog legislation for good as it reaches Report Stage in the House of Lords today.
Over 10,000 people signed up to support it and animal welfare organisations and charities throughout the UK are backing it; Lord Redesdale's Dog Control Bill would replace the widely criticised Dangerous Dogs Act (1991), by targeting the inappropriate behaviour of any dog, and more importantly the owners of such dogs, to reduce the occurrence of serious dog incidents, rather than continuing to demonise specific breeds or types.
The Bill is championed by the Dangerous Dogs Act Study Group (DDASG), a wide-ranging group representing animal welfare, local authorities and veterinary professional organisations who have been actively involved in resolving the inadequacies of the current 'dangerous dog' legislation for many years.
The DDASG considers that the Dangerous Dogs Act needs to be overhauled to better protect the public and that a new dog control regime which emphasises responsible dog ownership should be introduced.
DDASG Chairman Chris Laurence said: "We have had considerable input into the Dog Control Bill and are confident that the Bill takes huge steps towards changing the manner in which owners of dogs that are out of control will be dealt with; the emphasis being on the prevention of dog bites."
The Report Stage of the Dog Control Bill is listed as the first item of business in the House of Lords on this morning and comes as Defra's public consultation on dangerous dogs shows further support for this approach with 71% of respondents calling for breed specific legislation to be repealed.
In support of the Bill, the DDASG launched a petition which has received over 10,000 signatures. The petition can be found at http://www.gopetition.com/petitions/repeal-and-replace-the-dangerous-dogs-act.html. The DDASG has also been working with other major stakeholders including the Royal Society for the Prevention of Cruelty to Animals and will be issuing a joint briefing to government tomorrow, entitled 'Finding solutions to irresponsible dog ownership' which outlines where urgent action must be taken in existing dog legislation to improve huge inadequacies within the law.
Subject to the Bill passing the Report Stage, the Third Reading will take place after summer recess before moving to the House of Commons for further consideration. For more information on the DDASG, Lord Redesdale's Dog Control Bill and current legislation, visit http://www.thekennelclub.org.uk/item/928.
At the same time as paying the fee, all veterinary surgeons must annually confirm their Register and correspondence details, declare any convictions, cautions or adverse findings and confirm they are compliant with RCVS continuing professional development (CPD) policy.
The deadline for completing the annual renewal, 1 April 2019, has now passed and all veterinary surgeons who are yet to pay their fees must do so before the end of May 2019. As of 1 June 2019, any non-payers will be removed from the Register.
If paid by 30 April 2019, the annual fee is £340 for UK-practising veterinary surgeons, £170 for veterinary surgeons practising outside the UK, and £56 for non-practising veterinary surgeons. Following this date, the fee goes up by £35 across all these groups and veterinary surgeons will have until 31 May 2019 to pay.
If the renewal fee is not received in full by 31 May 2019, then non-paying veterinary surgeons will be removed from the Register. In order to restore their name to the Register, a restoration fee of £340 will need to be paid, in addition to the appropriate retention fee. During this time they will not be able to use the postnominals MRCVS and UK-practising vets will need to cease practising.
Annual renewals can be completed online on the RCVS website and all the information needed to complete the annual renewal is in the renewal notice that has been sent to veterinary surgeons. Those who need any help or have any questions about completing their renewal and paying fees should contact the RCVS Registration Department on 020 7202 0707 or registration@rcvs.org.uk.
The GDP offers one-to-one mentoring, alongside professional and clinical skills development in primary care practices across the UK.
Chloe Roberts, clinical and educational development manager at Linnaeus, said: “This fourth cohort of graduates is looking likely to be the biggest yet, which is testament to how successful the programme has become over recent years.
“We’ve received so many high-quality applications and look forward to welcoming many of them into our practices.
“There’s still time left for people to apply via our online portal, so we’d love to hear from any prospective candidates interested in roles in the Midlands and Yorkshire.”
Linnaeus delivers all clinical training in-house through its extensive network of specialists, referral clinicians, certificate holders and experienced primary care clinicians.
Graduates take part in 20 core educational days as part of their clinical and professional skills training, with access to an additional 10 CPD days to undertake training of their own choice over the course of the programme.
For more information about the Graduate Development Programme, visit https://graduates.linnaeusgroup.co.uk.
Photo: Bristol University graduate Abigail McCarthy, a vet at Blacks Vets in Dudley
They say that they've been aware of minor interruptions to the supply of such vaccines throughout 2022.
However, a significant, pan-European logistical problem being experienced by Boehringer Ingelheim has raised the prospect of a further reduction in supplies in the coming months.
BEVA is liaising with the three vaccine manufacturers to quantify the impact of the shortage and to consider solutions, both to minimise the threat to equine health and to prevent disruption to equestrian competition.
Marc Laemmer, equine business head at Boehringer Ingelheim Animal Health, said: “We are currently experiencing a European-wide supply issue relating to our equine influenza and influenza-tetanus vaccines.
"This has been caused by unexpected issues following the implementation of a technology upgrade and is not a product or quality issue.
"This means that some vet practices will have difficulty obtaining sufficient influenza vaccines and there may be a shortage in the UK market.
"We understand the importance of these vaccines to equine welfare, and we are continuing to work tirelessly to find a solution so that we can return to normal supply as soon as possible.”
Amanda Melvin, equine business manager at MSD Animal Health, said: “Based on prior demand, MSD’s equine vaccines Equilis Prequenza and Equilis Prequenza Te are in full supply.
"MSD have taken steps to protect as many horses as possible at this time.
"We will continue to supply existing customers with the available MSD stock on ‘allocation’ and, where possible, to allocate stock to additional customers. Allocations are being made to our veterinary customers based on their historical demand which we believe is the most efficient way to manage the available supplies.”
Rebecca Cabrejas, equine business unit manager at Zoetis, said: “Demand for our vaccines currently exceeds what we can supply.
"Whilst we have adequate stocks to fulfil current customers’ orders unfortunately, we are not in a position to be able to supply new customers at this time.
"We will continue to work with BEVA to limit the impact of the current shortages.”
Ronnie (pictured right) will look at quality control and artefacts of sample quality and review the effects of different pathologies. By examining analyser output, he'll demonstrate how abnormalities of cells and plasma may affect measured parameters and their indices.
Using images, photomicrographs and video links, he'll move onto explain the techniques and equipment needed to complement analytical automation in order to confirm results quality.
Ronnie said: "“We now have more near patient testing in veterinary haematology than ever before. Quality is key to best practice and ultimately superior patient care. Sod’s Law states that ‘if something can go wrong, it will!’, so along the way to your generating a Complete Blood Count, it pays to be aware of some of the pitfalls that you may encounter.
“One should never underestimate the value of gross exam and simple methods that can be used to ensure sample quality and results accuracy. Seeing is believing after all!”
There will also be an open Q&A session with Ronnie after the presentation, so attendees are invited to bring any questions on all things haematology.
To register for the webinar, visit: https://register.gotowebinar.com/register/2458623866746094093
Companion Consultancy Director Susan Mackay, herself a veterinary surgeon, started Companion Consultancy in 2002.
She said: “We added a design team to the agency two years ago and it’s been fantastic to have this resource available in-house.
"In the digital space people increasingly consume their content as images and sound as much as the written word and it has become key to delivering communication projects that really work.”
VetSurgeon.org editor Arlo Guthrie said: "I couldn't agree with Susan more.
"As a news editor, I get a barrage of press releases every day.
"Those with powerful photos or video that will stand out on all the different social media platforms get prioritised.
"Those that have poor images, or none at all tend to get ignored."
Susan added: “For complex projects we can have one or more of our vets working alongside the designer to get all the technical nuances exactly right.
"Infographics for instance are a great way to overcome language barriers but explaining the complexities of how vaccines work in pictures needs veterinary input and our designers then come up with visual ways to represent those concepts so we can work through those together.
"On simpler projects, clients don’t have to waste time explaining why they don’t want to show a dog wearing a choke chain or carrying a stick, because our designers already bring an additional level of understanding to their work.
"We want to make it clear that you don’t have to be a Companion Consultancy client to benefit from this great resource.”
Companion Design Studio is offering a free, no obligation 30 minute design consultation to the first 10 applicants from the veterinary community who want expert input on their existing branding and how it has been applied, or to gather ideas for new design projects.
www.companiondesignstudio.co.uk or call Tom on 07925 133302.
The ESVE has become aware through its Endocrine Quality Assurance (EQA) Scheme that there will be a permanent change in the antibody used for the cortisol test for the Siemens Immulite 2000.
The change affects the antibody pool from kit Lot 550 onwards, meaning that it has already affected some laboratories and others will be affected in the next few weeks to months. At present, the new antibody lots are not being released to the USA market. Other analysers are unaffected.
The ESVE has been working with the laboratories in its EQA scheme to quantify the impact on results and reference limits. The Society says an initial review by the ESVE-EQA based on >400 canine serum and >40 urine results suggests that canine serum cortisol results are lower (average bias -23% in canine serum) than diagnostic laboratories and clinicians have been used to in the past. The effect is more marked in canine urine cortisol (average bias -70%).
Since being alerted by the ESVE-EQA, the manufacturer has derived mathematical adjustment factors that laboratories can incorporate into their systems to mitigate the impact on results. If the manufacturer adjustment is used, then the results will be around 8% lower on average in serum and around 60% lower in urine. Cut-offs to diagnose hyperadrenocorticism and rule out hypoadrenocorticism may need to be validated again with the new assay. There is not yet sufficient data in the ESVE-EQA collaboration to assess the impact on feline and equine samples.
Professor Ian Ramsey, President of the BSAVA and one of the founders of ESVE, said: “Individual laboratories may have different ways of dealing with this change and therefore it is important to keep in touch with your laboratory provider concerning their approach. Some may choose to make the mathematical adjustments to results so that common and historic cut-off values can continue to be used. Others may report their results directly but change their guidance on interpretative cut-off values."
Dr Peter Graham, ESVE-EQA Co-ordinator, concluded: “ESVE advises that all cortisol results from Siemens Immulite 2000 assays that are close to a threshold are interpreted cautiously. ESVE also advises that all endocrine results should be interpreted in the light of clinical findings and would like to remind clinicians that spurious results may occur in any assay, though this is rare.”
The BSAVA and ESVE encourage laboratories to tell clinicians which analyser they are using. Suitable wording regarding the interpretation of any values of cortisol based on Siemens Immulite 2000 results should be provided by laboratories for the foreseeable future.
Photo: A dog with hyperadrenocortism, courtesy Professor Ian Ramsey
The Animal Health Trust is appealing to veterinary surgeons and nurses to encourage clients who keep their horses on premises that have been affected by Equine Grass Sickness to sign up to the second year of its nationwide EGS vaccine trial.
Equine Grass Sickness (EGS) occurs predominantly in Europe, with Britain experiencing the highest incidence worldwide. In 2014, 59 cases of EGS were reported through the EGS Surveillance Scheme, but it is likely that this represents only a fraction of cases occurring annually throughout Britain.
Almost all cases of EGS occur in horses with access to grazing. The AHT says there is growing scientific evidence to suggest that the disease may be caused by the bacterium Clostridium botulinum type C, commonly found within soil and capable of producing neurotoxins to which horses are particularly sensitive. EGS occurs when a combination of risk factors trigger the production of these toxins within the horse's intestinal tract, causing damage to the nervous system and paralysis of the gut.
As similar equine diseases such as tetanus and botulism can be prevented by vaccination, it is theoretically possible that a vaccine could prevent EGS. To this end the AHT, in collaboration with the Universities of Edinburgh, Liverpool and Surrey launched the EGS field vaccine trial in 2014 in order to establish whether a vaccine could indeed be effective in reducing the risk of the disease. The trial is funded by a number of sources including Neogen Corporation; Animal Welfare Foundation; Horserace Betting Levy Board; Racing Foundation; Moredun Foundation Equine Grass Sickness Fund; Hong Kong Jockey Club; The British Horse Society and the EB Moller Charitable Trust.
Now entering its second year, the EGS vaccine trial involves enrolled horses and ponies receiving either a course of the C. botulinum type C toxoid vaccine or an inactive placebo, as well as an annual booster. The incidence of EGS is monitored throughout the trial to determine the efficacy of the vaccine, and enrolled horses and ponies are closely monitored through regular follow-ups for the duration of the trial.
With 60% of EGS cases occurring during April - June, the highest risk season for EGS is fast approaching. The AHT is appealing to owners who keep their horses on premises that have had at least one case of EGS in the past three years to enrol their horse in the vaccine trial and provide an invaluable contribution to this pioneering research prior to these high risk months. Veterinary practices with clients who fit this description are asked to help the recruitment process by encouraging suitable cases to sign up to the trial.
Dr Jo Ireland, the AHT's Equine Grass Sickness Research Co-ordinator, said: "We have been delighted with the overwhelmingly positive response to the EGS vaccine trial and many owners have welcomed the chance to be a part of such important research. We don't want any eligible horse owners to miss out on the opportunity to contribute towards a potential breakthrough in the prevention of EGS, so we are encouraging more owners to enrol their horses on the trial this year."
To find out more about the vaccine trial or how clients can enrol horses and ponies, visit the AHT's dedicated EGS website www.equinegrasssickness.co.uk or email equinegrasssickness@aht.org.uk.
International Cat Care has announced the winners of four new ‘Easy to Give’ awards and three ‘Cat Friendly’ awards.
The Easy to Give award was created to reward pharmaceutical companies whose products are easy to administer to cats. Previous examples have included drugs in a highly palatable form, smaller tablets, longer lasting preparations or those with an easier mode of administration.
Easy to Give winners this year are Virbac's Prinovox (ectoparasiticide), Norbrook's Loxicom (NSAID), and Ceva's Vectra Felis (ectoparasticide) and Zodon (antibiotic).
These latest winners bring the total number of Easy to Give awards presented, since their inception in 2005, to 35.
International Cat Care CEO, Claire Bessant, said: ‘It is so important that cats receive treatments prescribed for them, whether it is for preventive care or to treat a problem. If a drug is too difficult to get into the cat, owners often fail to complete the course, leaving the cat inadequately treated – as we worry about antibiotic resistance, this is particularly important beyond the individual animal too. Struggling with a cat to medicate can put a tension into the owner/cat relationship at a time when owners feel they want to be more supportive rather than seen as something to fear. This year we asked those trying the products if the act of medication had a negative effect on their relationship with their cat, as many people find that in the struggle to medicate, often the cat becomes fearful or aggressive towards them which owners also find very distressing. This kind of innovation by pharmaceutical companies is essential to feline health.’
Easy to Give awards are confined to prescription only medicines (POMs) or methods of delivering POMs. International Cat Care also recognises other products which have made a difference to cat wellbeing and welfare, with its Cat Friendly Awards.
The Cat Friendly Awards go to the SoftE Smart Collar from MDC, the SureFeed Microchip Pet Feeder from SureFlap and the Cat Carrier Tree from Royal Canin.
For more details on the work of the charity go to www.icatcare.org.
VetSurgeon member Anthony Todd has started a petition amongst veterinary surgeons and nurses, calling for the installation and routine monitoring of CCTV in all pre-slaughter areas of licensed abattoirs in the UK.
The petition was triggered by a news report in the Daily Mail exposing shocking cruelty to pigs at an Essex slaughterhouse run by Cheale Meats. Staff were seen stubbing their cigarettes out on the pigs' faces, punching them and failing to stun the animals correctly, in undercover footage filmed by Animal Aid.
The Food Standards Agency, which is responsible for breaches of welfare at abattoirs, has refused to submit the footage to Defra for prosecution, on the basis that it was filmed illegally.
Anthony said: "Prosecution will automatically follow with legal video evidence.
"The exposure of the Cheale incident was fortuitous and may well be the tip of the iceberg which must be eliminated."
To sign the petition, please visit: http://www.ipetitions.com/petition/abbatoir-abuse/
BSAVA has launched its Postgraduate Certificate website.
The site contains all of the online materials and activities which support the BSAVA postgraduate certificates. The BSAVA says students enrolled on the programmes will find it invaluable.
There are also sections of the site for those who have agreed to act as mentors for students enrolled on the programme, and exclusive material for BSAVA members who missed out on enrolment in 2012, but have pre-enrolled for 2013.
The BSAVA Postgraduate Certificate website may be found via the CPD section at http://www.bsava.com/ (direct link http://www.bsavaeducation.co.uk/). If you would like to know more about the BSAVA Postgraduate Certificate programmes, please email certificate@bsava.com.
Free-range table-birds being reared from slower growing breeds need a different vaccination regime from that of faster-growing broilers, when being immunised against Gumboro disease.
This previously-unknown fact has emerged from laboratory and field trials, involving several hundred thousand birds on farms throughout the UK, carried out by Lohmann Animal Health in conjunction with poultry vets.
"When using a ‘hot' vaccine conventional broilers in the UK are normally vaccinated at around 14-16 days when their maternal immunity is waning," said Adam Goddard, Lohmann's UK sales consult. "However, we've found this maternal immunity lasts longer in the slow-growing breeds which are reared both indoors and out."
Realistically, the correct day of vaccination for free-range table-birds is more likely to be achieved by using the vaccine date predictions for broiler-breeders, rather than that of the broiler, under the Deventer formula, which gives calculations for different types of bird.
He therefore advises producers to consult their vets who can take blood samples to get an accurate prediction regarding optimum timing of vaccination with their own particular flocks.
"Our trials have shown that, in general, and depending upon the breed used, the decline in maternal immunity is delayed - perhaps for 4-5 days. So, in order to get a better ‘take', we recommend vaccinating these birds later or using an IBD vaccine that ‘takes' in the presence of high maternal immunity." said Mr Goddard.
Gumboro disease - also known as Infectious Bursal Disease - can cause severe losses in chickens and outdoor-reared birds are more susceptible to the disease due to environmental influences.
Earlier this year Lohmann Animal Health launched a new ‘hot' vaccine, classified as an ‘intermediate plus' against the very virulent form of Gumboro disease. The company says that because of its ability to break through high levels of maternal antibodies, it allows vaccination to take place earlier than with other existing vaccines.
The British Veterinary Association's Members' Services Group has devised a Vet Helpline sticker as a practical way to promote the help and support available to members of the veterinary profession suffering from anxiety or depression. It will be sent out with the 20th February edition of the Veterinary Record.
The suicide rate within the veterinary profession is around four times higher than in the general population and around twice that of other high risk groups including farmers and medical practitioners. Research has shown that long hours, the risk of professional mistakes and rising client expectation and administrative work lead to high levels of anxiety and depressive symptoms. Ready access to and knowledge of lethal means such as medicines and firearms may also be contributing factors in the increased suicide risk.
The Vet Helpline sticker acts as a constant reminder to veterinary professionals that a confidential helpline, manned by trained volunteers from the veterinary profession, is available around the clock on every day of the year to offer support and direct them to specialist help where appropriate. In addition to the Vet Helpline phone number the sticker also gives the number for the Samaritans and includes the address of the Vetlife website which is a "one stop shop" for all the help available.
BVA President, Professor Bill Reilly, said: "Please remember that if you're feeling depressed, lonely or under pressure, or are perhaps worried about a colleague, you can talk it over in confidence with trained volunteers from the veterinary profession. The Vet Helpline is there for all veterinary surgeons, nurses and students.
"Ours is a small profession and sadly most of us know someone who has suffered mental ill health or taken their own life. We hope that by reminding colleagues how to get help and continuing to publicise the Vetlife website and the Veterinary Benevolent Fund support services the BVA can play its part in supporting vets in crisis."
An international group of scientists has published new results that herald a breakthrough in finding a vaccine against the most commonly diagnosed infectious disease of horses, strangles.
UK experts from the Animal Health Trust collaborated with scientists from the Swedish University of Agricultural Sciences (SLU), the Karonlinska Institutet Medical University and Intervacc AB, on the project - the results of which could benefit humans as well as animals.
Professor Andrew Waller, Head of Bacteriology at the AHT, said: "We have been working towards developing a vaccine for 7 years, and finally it seems as if all the hard work is paying off. We've already developed better ways of diagnosing exposure to the infection, and now, with the success of creating a safe and effective vaccine, it looks as if we're finally bringing together the tools necessary to eradicate this terrible disease."
The vaccine consists of seven different Streptococcus proteins and results from early tests published in PLoS Pathogens have been incredibly positive showing a high level of protection and no side effects. It is hoped that the strangles vaccine could be commercially available in the near future.
Streptococcus equi, the bacterium that causes strangles, shares 80 per cent identity with Streptococcus pyogenes - the leading cause of bacterial pharyngitis, tonsillitis and rheumatic fever in humans, which kills thousands of people each year. Scientists hope that the knowledge gained through developing the strangles vaccine will also help in developing vaccines to combat these human conditions.
Research leader, Professor Bengt Guss of SLU, said: "This is a most exciting project, where research is generating new applications and knowledge that can be used to develop vaccines against these important bacteria. This is particularly important considering the increased number of infectious diseases caused by antibiotic-resistant bacteria."
The vaccine development work was only made possible thanks to information from the Streptococcus equi genome sequencing project funded by The Horse Trust.
The Horse Trust's Chief Executive Brigadier Paul Jepson, said: "We are absolutely delighted that by pulling apart the genome of this plague of the horse world scientists have generated a truly safe and effective strangles vaccine. That this work could also benefit other animal and human health is beyond our wildest hopes."
Full text of the research findings can be found in PLoS Pathogens online at http://www.plospathogens.org/article/info%3Adoi%2F10.1371%2Fjournal.ppat.1000584
Vetoquinol has revamped its Epiphen complimentary voucher scheme for testing serum levels of phenobarbital, and is offering vet practices a chance to win £100 of high street vouchers.
New voucher pads will be posted to participating veterinary practices in August. The re-vamped scheme also includes freepost envelopes to make the free serum monitoring programme more user-friendly.
Practices are being asked to send back the old vouchers, which can be found in both the 30mg and 60mg Epiphen packs, to take part in a monthly prize draw to win £100 of high street vouchers. To enter, return the vouchers with the practice name on the back of each voucher. There will also be a quarterly prize draw for a "Touch Screen" client education tool.
The old vouchers should be sent to: Voucher Amnesty, Vetoquinol, Vetoquinol House, Great Slade, Buckingham Industrial Park, Buckingham, MK18 1PA.
Avid has released a new version of it's microchip registration system, which offers a significantly enhanced statistical analysis of the microchipping done at your practice.
The new MicroChip Plus section of the site is specifically for implanters, and contains the following:
Avid says the registration system, which has built-in postcode software, can now re-use more registration details, so that registering a complete litter will take less time. This is especially important when microchips are being registered for or by breeders.
Denise Chaloner, Manager at Avid said: “Avid MicroChip Plus gives our customers more control of how they manage pet microchipping within their organisation. Listening to feedback has inspired Avid to develop a more tailor-made and efficient system for the end user, also enabling the generation of reports, statistics and targets”.
Customers with supporting practice management systems may register microchips directly from their software using VetXML and VetEnvoy.
For more information contact Avid on freephone 0800 652 7 977 or email sales@avidplc.com
BVA members who join the Webinar Vet before the end of this month will receive a USB headset and microphone worth £40
Webinar Vet founder Anthony Chadwick MRCVS said: "The idea is to help new members get equipped and ready to listen and ask questions during the regular Thursday evening member webinars."
"BVA members already benefit from half price gold membership to the Webinar Vet and many have already taken advantage and are enjoying the many benefits of online CPD."
Gold membership includes invitations to weekly members' live CPD events, full access to the library of over 150 hours of categorised pre-recorded webinars, and a monthly CD of one of the presentations to listen to in the car.
All BVA members who sign up before March 31st will also qualify for the free headset. For more information visit www.bva.co.uk/webinar.
The RVC says that until now, there has been little reliable evidence on the frequency and severity of syringomyelia in the overall dog population, which has limited veterinary surgeons’ ability to diagnose and manage the condition.
It's not just syringomyelia for which there is a lack of data. Scientists have for years struggled to identify the true extent and severity of diseases seen in the wider general dog population because the main source of veterinary health data on dogs has come from universities and referral hospitals.
While this referral data is useful, the types of animals and conditions that are referred to these referral centres is unrepresentative of the wider dog population, making it very difficult to extrapolate any findings to the general population. The vast majority of animals are managed perfectly well by the primary vet practitioners without ever being referred or even being ill at any one time.
However, through VetCompass, the RVC is now collecting anonymised clinical data from first opinion veterinary clinics across the UK; data which is being analysed to answer a wide variety of previously unanswerable health questions.
The VetCompass syringomyelia study published in the Veterinary Record is a case in point. It highlights for the first time the frequency and severity of syringomyelia seen in general practice in the UK.
At an overall dog population level, syringomyelia is not that common, affecting just one in 2,000 dogs. But among Cavaliers, the frequency of syringomyelia is much higher, affecting one in every 60 of the breed. VetCompass data reveals that almost 2,000 Cavaliers suffer from clinical syringomyelia in the UK at any one time.
Syringomyelia is a severe condition for affected dogs, with the VetCompass study showing that 72% of affected dogs were recorded as showing pain. The study showed that these dogs would often yelp or scream when they were picked up or when their necks were touched. Many of them also showed ‘phantom scratching’ where they would try to scratch at their necks with their hindlegs but without ever even making contact with the skin. Some people refer to this action as ‘playing an air guitar’.
The RVC is urging veterinary surgeons and owners alike to be aware of the symptoms of syringomyelia, so that clinically affected dogs can be recognised and treated earlier and better. Symptoms include:
Dr Dan O’Neill, Companion Animal Epidemiologist at the RVC, said: "I loved being a first opinion practice vet for over 20 years where I could help animals on a one-by-one basis. But now, with VetCompass, we can help animals by their thousands. An example is this syringomyelia study which may lead to many affected dogs getting treatment much earlier and therefore making their lives so much better."
Professor Holger Volk, Professor of Veterinary Neurology and Neurosurgery, said: “These VetCompass data are an eye-opener; we very frequently see Cavaliers with clinical signs of syringomyelia at RVC’s referral hospital but now we know how common it is in the real world, outside of the referral world."
Dr Ludovic Pelligand, Senior Lecturer in Clinical Pharmacology and Anaesthesia, said: “VetCompass allows us to identify how Cavalier King Charles affected by syringomyelia are treated for pain every day, nationwide. This will help us to understand optimal management and we are currently working on new ways to monitor pain and working towards developing new treatment options to further improve their pain relief and quality of life in the future".